The largest database of trusted experimental protocols

3 protocols using anti cd3 bv421 clone 17a2

1

Hepatitis B Virus-like Particle Immunogenicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
For DC activation, 5 × 104 DCs were co-cultured with various concentrations of HBc VLPs for 24 h. The supernatant of the DCs was collected for IL-12-p40 measurement. The cells were collected and stained with anti-CD11c-APC-eF780, anti-CD40-APC, anti-CD86-PE-cy7, anti-I-Ab, and DAPI, and then analyzed on an LSR-II flow cytometer. For B cell activation, 6–12-week-old female C57BL/6J mice were inoculated on the right flanks with 4 × 105 MC-38 cells in 100 μL PBS. When mice displayed established tumors, the mice were sacrificed to collect splenocytes (n = 3). Next, 1 × 106 splenocytes were co-cultured with various concentrations of HBc VLPs for 24 h. The supernatant of the splenocytes was collected to measure the IFN-γ levels using an IFN-γ Mouse ELISA Kit (Invitrogen, Waltham, MA, USA). Thereafter, the cells were washed three times with phosphate-buffered saline (PBS) and stained with anti-CD45.2-APC-ef780 (clone 104, Thermo Fisher, Waltham, MA, USA), anti-CD3-BV421 (clone 17A2, Biolegend, San Diego, CA, USA), anti-CD19-BV655 (clone 6D5, Thermo Fisher, USA), anti-CD40-APC (clone 3/23, Biologend, San Diego, CA, USA), anti-CD86-FTIC (clone GL1, Thermo Fisher, Waltham, MA, USA) before analysis by means of flow cytometry.
+ Open protocol
+ Expand
2

Cytokine Profiling of Synovial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve synovial cells were used to analyze their Foxp3 expression profile, while the expression of IL-17A and IFNγ was assessed after in vitro stimulation of 8 × 106 cells with 20 ng/ml PMA (Sigma-Aldrich) and 1 μg/ml Ionomycin (Sigma-Aldrich) in a 6-well flat-bottom plate (Falcon) for 6 h. To prevent cytokine GolgiPlug (BD) (1 μl/ml) and GolgiStop (0,6 μl/ml) (BD) were added after the first hour in culture. Afterwards cells were washed and stained for the expression of CD3 (anti-CD3-BV421, clone 17A2; BioLegend), CD4 (anti-CD4-APC-Fire, clone RM4-5; BioLegend), CD8 (anti-CD8-FITC, clone 53-6.7; BioLegend), CD19 (anti-CD19-PerCP Cy5.5, clone 6D5; BioLegend), CD25 (anti-CD25-PerCP Cy5.5, clone PC61; BioLegend), and living cells using L/D Aqua in BV510 (BioLegend) for 40 min at 4°C. Further, cells were prepared for intracellular staining using the Fixation/Permeabilization solution kit (Thermo Fisher Scientific). Antibodies for Foxp3 (anti-Foxp3 AF647, clone FJK-16s; eBioscience), IFNγ (anti-IFNγ-PE-Cy7, clone XMG1.2; BD), and IL-17A (anti-IL-17A-AF647, clone TC11-18H10.1; BioLegend) were diluted in permbuffer (Thermo Fisher Scientific) and applied to the cells for 30 min at 4°C. The flow cytometric analyses were performed using a cytofluorometer (FACS Canto II, BD) and data were evaluated using FCS-express 5 (De Novo Software).
+ Open protocol
+ Expand
3

Multiparameter Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For FACS analysis, the following antibodies were used: anti-CD3-Bv421-(clone 17A2, Biolegend), anti-CD4-Bv421 (clone RM 4-5, eBioscience), anti-CD8-FITC (clone 53-6.7, Biolegend), anti-CD25 PE (clone PC61, Biolegend), anti-CD27-APC (clone LG.3A10, Biolegend), anti-CD11b-FITC (clone M1/70, Biolegend), anti-CD11b-Bv421 (clone M1/70, Biolegend), anti-FceRIα-PE (MAR-1, Biolegend), anti-F4/80-PE (BM8, Biolegend), anti-CD45-APC/Cy7 (30-F11, Biolegend), anti-CD107a-FITC (1D4B, Biolegend) and anti-P2X7-AF647 (clone Hano44, UKE) (Adriouch et al., 2005) (link). Flow cytometric analyses were performed on a BD Fortessa (Beckton Dickinson) or a BD FACS CantoII (Beckton Dickinson).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!